QTL for morphine antinociception on Chr10 at D10Mit51 (19.52 Mbp , Build 37)
Description:
morphine antinociception spans 0.00 - 44.52 Mbp (NCBI Build 37) on Chr10. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
Authors:
Bergeson SE, Helms ML, O\'Toole LA, Jarvis MW, Hain HS, Mogil JS, Belknap JK
QTL for morphine preference on Chr10 at D10MIT282 (24.33 Mbp , Build 37)
Description:
morphine preference spans 0.00 - 49.33 Mbp (NCBI Build 37) on Chr10. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
Authors:
Berrettini WH, Ferraro TN, Alexander RC, Buchberg AM, Vogel WH
QTL associated with amphetamine distance traveled 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (20654078)
Authors:
Torkamanzehi A, Boksa P, Ayoubi M, Fortier ME, Ng Ying Kin NM, Skamene E, Rouleau G, Joober R
QTL associated with atherosclerotic lesion area 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (21435099)
QTL associated with atherosclerotic lesion area 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (18526522)
QTL associated with experimental allergic encephalomyelitis susceptibility 15. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (21252061)
QTL associated with myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody QTL 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (28871992)
Authors:
Hamano Y, Tsukamoto K, Abe M, Sun GD, Zhang D, Fujii H, Matsuoka S, Tanaka M, Ishida-Okawara A, Tachikawa H, Nishimura H, Tokunaka K, Hirose S, Suzuki K
QTL associated with postnatal body weight growth 9. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (21435099)
QTL associated with proteoglycan induced arthritis 6. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (20654078)
Authors:
Glant TT, Adarichev VA, Nesterovitch AB, Szanto S, Oswald JP, Jacobs JJ, Firneisz G, Zhang J, Finnegan A, Mikecz K
QTL associated with susceptibility to lung cancer 29. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (9133173)
QTL associated with SGC/Knj cross B6 QTL 4. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (28871992)
Authors:
Hamano Y, Tsukamoto K, Abe M, Sun GD, Zhang D, Fujii H, Matsuoka S, Tanaka M, Ishida-Okawara A, Tachikawa H, Nishimura H, Tokunaka K, Hirose S, Suzuki K
QTL associated with voluntary alcohol consumption QTL 6. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (11362694)
Drug Naïve DO mice were tested for open field, light dark, hole board, novelty place preference before collecting the striatum. RNA-Seq data was analyzed with WGCNA using a soft thresholding power of 3 selected using the WGCNA scale-free topology R2 threshold of 0.9, signed network with a minimum module size of 30, correlation type is bicor, used numeric labels.
The current study used two inbred mouse strains, C57BL/6 J and A/J, to investigate the genetics of behavioral responses to fentanyl. Mice were tested for conditioned place preference and fentanyl-induced locomotor activity. C57BL/6J mice formed a conditioned place preference to fentanyl injections and fentanyl increased their activity. Neither effect was noted in A/J mice. We conducted RNA-sequencing on the nucleus accumbens of mice used for fentanyl-induced locomotor activity. Surprisingly, we noted few differentially expressed genes using treatment as the main factor. However many genes differed between strains.
Authors:
Samuel J Harp, Mariangela Martini, Will Rosenow, Larry D Mesner, Hugh Johnson, Charles R Farber, Emilie F Rissman
Subset dataset of differentially expressed genes at padj < 0.05 of GS407879.
Authors:
Samuel J Harp, Mariangela Martini, Will Rosenow, Larry D Mesner, Hugh Johnson, Charles R Farber, Emilie F Rissman
Add Selected GeneSets to Project(s)
Warning: You are not signed in. Adding these genesets to a project will create a guest account for you.
Guest accounts are temporary, and will be removed within 24 hours of creation. Guest accounts can be registered as full accounts, but you cannot associate a guest account with an existing account.
If you already have an account, you should sign into that account before proceeding.